The Biopharmaceutical Alliance has been established to tackle the drug supply shortages that emerged during the Covid-19 pandemic. This coalition comprises five key participants: South Korea, India, the United States, Japan, and the European Union (EU).
The primary aim of this alliance is to enhance the resilience of the biopharmaceutical supply chain. By collaborating, these nations seek to ensure a more reliable and efficient supply of essential medicines.
The alliance includes government officials and representatives from bio and pharmaceutical companies across the member nations. This diverse representation is crucial for addressing the complexities of drug supply issues.
The participating countries will coordinate their bio policies, regulatory frameworks, and research and development support measures. This collaboration is expected to facilitate faster responses to future health crises.
There is a pressing need for a comprehensive pharmaceutical supply chain map. This tool is essential to reduce dependence on a limited number of countries for critical raw materials and ingredients, which can jeopardize global health security.
Biopharmaceuticals are medical drugs created using biotechnology. They encompass a range of products, including proteins (like antibodies), nucleic acids (such as DNA and RNA), and living cells, all used for therapeutic or diagnostic purposes. These drugs are often more complex and targeted compared to traditional pharmaceuticals.
The Bio International Convention serves as a global platform where representatives from biotechnology and pharmaceutical companies, academia, and government agencies gather to discuss advancements in the biotechnology sector. This event plays a significant role in promoting innovation and collaboration.
The inception of the Biopharmaceutical Alliance followed discussions between South Korea and the United States in December. This dialogue has since expanded to incorporate Japan, India, and the EU, highlighting a unified approach to addressing global health challenges.
Q1. What is the Biopharmaceutical Alliance?
Answer: The Biopharmaceutical Alliance is a coalition formed by South Korea, India, the U.S., Japan, and the EU to improve drug supply chain resilience following Covid-19 shortages.
Q2. Why is a pharmaceutical supply chain map important?
Answer: A pharmaceutical supply chain map is essential to minimize dependence on a few countries for critical raw materials, ensuring a stable supply of medicines globally.
Q3. What are biopharmaceuticals?
Answer: Biopharmaceuticals are medical drugs developed through biotechnology, including proteins, nucleic acids, and living cells, often providing targeted therapies.
Q4. How did the Biopharmaceutical Alliance begin?
Answer: The alliance originated from discussions between South Korea and the U.S. in December, later expanding to include Japan, India, and the EU.
Q5. What is the purpose of the Bio International Convention?
Answer: The Bio International Convention is a global event aimed at promoting advancements and collaboration in the biotechnology and pharmaceutical sectors.
Question 1: What is the main goal of the Biopharmaceutical Alliance?
A) To reduce healthcare costs
B) To enhance drug supply chain resilience
C) To develop new vaccines
D) To promote traditional medicine
Correct Answer: B
Question 2: Which countries are part of the Biopharmaceutical Alliance?
A) South Korea and China
B) India and Brazil
C) South Korea, India, U.S., Japan, and EU
D) Japan and Russia
Correct Answer: C
Question 3: What type of products do biopharmaceuticals include?
A) Only synthetic drugs
B) Proteins, nucleic acids, and living cells
C) Herbal medicines
D) Over-the-counter medications
Correct Answer: B
Question 4: Why is international coordination important in the Biopharmaceutical Alliance?
A) To increase competition
B) To streamline bio policies and regulations
C) To limit pharmaceutical production
D) To promote individual country interests
Correct Answer: B
Question 5: When did the discussions for the Biopharmaceutical Alliance begin?
A) January 2021
B) December 2022
C) December 2020
D) June 2021
Correct Answer: C
Kutos : AI Assistant!
